{
    "organizations": [],
    "uuid": "034fe03a6da65bd08103e3906b36d7427e6d076d",
    "author": "",
    "url": "https://www.reuters.com/article/brief-takeda-and-denali-therapeutics-col/brief-takeda-and-denali-therapeutics-collaborate-to-develop-therapies-for-neurodegenerative-diseases-idUSFWN1P00D7",
    "ord_in_thread": 0,
    "title": "BRIEF-Takeda And Denali Therapeutics Collaborate To Develop Therapies For Neurodegenerative Diseases",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 15 PM / in 6 minutes BRIEF-Takeda And Denali Therapeutics Collaborate To Develop Therapies For Neurodegenerative Diseases Reuters Staff \nJan 5 (Reuters) - Takeda Pharmaceutical Co Ltd: \n* TAKEDA AND DENALI THERAPEUTICS COLLABORATE TO DEVELOP AND COMMERCIALIZE THERAPIES FOR NEURODEGENERATIVE DISEASES \n* DENALI THERAPEUTICS - TAKEDA TO MAKE AN INITIAL PAYMENT TO CO OF $150 MILLION THROUGH COMBINATION OF CASH UPFRONT PAYMENTS AND PURCHASE OF DENALI EQUITY \n* DENALI THERAPEUTICS - TO BE RESPONSIBLE FOR DEVELOPMENT ACTIVITIES AND COSTS PRIOR TO IND FILING FOR EACH OF THREE PROGRAMS \n* DENALI - WILL BE ELIGIBLE TO RECEIVE DEVELOPMENT & COMMERCIAL MILESTONE PAYMENTS, INCLUDING $90 MILLION IN PRECLINICAL MILESTONES & OPT-IN PAYMENTS \n* DENALI THERAPEUTICS - COLLABORATION AGREEMENT TO DEVELOP,COMMERCIALIZE UP TO 3 SPECIFIED THERAPEUTIC PRODUCT CANDIDATES FOR NEURODEGENERATIVE DISEASES \n* DENALI - TAKEDA, CO WILL JOINTLY COMMERCIALIZE PRODUCTS IN U.S., CHINA, TAKEDA WILL HAVE EXCLUSIVE COMMERCIALIZATION RIGHTS IN ALL OTHER MARKETS \n* DENALI THERAPEUTICS - TAKEDA, CO WILL SHARE GLOBAL PROFITS FROM COLLABORATION EQUALLY \n* DENALI THERAPEUTICS INC - TAKEDA HAS OPTION TO CO-DEVELOP AND CO-COMMERCIALIZE EACH OF THREE PROGRAMS Source text for Eikon: Further company coverage:",
    "published": "2018-01-05T14:14:00.000+02:00",
    "crawled": "2018-01-05T14:32:31.077+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "minute",
        "denali",
        "therapeutic",
        "collaborate",
        "develop",
        "therapy",
        "neurodegenerative",
        "disease",
        "reuters",
        "staff",
        "jan",
        "reuters",
        "takeda",
        "pharmaceutical",
        "co",
        "ltd",
        "takeda",
        "denali",
        "therapeutic",
        "collaborate",
        "develop",
        "commercialize",
        "therapy",
        "neurodegenerative",
        "disease",
        "denali",
        "therapeutic",
        "takeda",
        "make",
        "initial",
        "payment",
        "co",
        "million",
        "combination",
        "cash",
        "upfront",
        "payment",
        "purchase",
        "denali",
        "equity",
        "denali",
        "therapeutic",
        "responsible",
        "development",
        "activity",
        "cost",
        "prior",
        "ind",
        "filing",
        "three",
        "program",
        "denali",
        "eligible",
        "receive",
        "development",
        "commercial",
        "milestone",
        "payment",
        "including",
        "million",
        "preclinical",
        "milestone",
        "payment",
        "denali",
        "therapeutic",
        "collaboration",
        "agreement",
        "develop",
        "commercialize",
        "specified",
        "therapeutic",
        "product",
        "candidate",
        "neurodegenerative",
        "disease",
        "denali",
        "takeda",
        "co",
        "jointly",
        "commercialize",
        "product",
        "china",
        "takeda",
        "exclusive",
        "commercialization",
        "right",
        "market",
        "denali",
        "therapeutic",
        "takeda",
        "co",
        "share",
        "global",
        "profit",
        "collaboration",
        "equally",
        "denali",
        "therapeutic",
        "inc",
        "takeda",
        "option",
        "three",
        "program",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}